Patents by Inventor Anne Louise Bank KODAL

Anne Louise Bank KODAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CNP compounds
    Patent number: 12077561
    Abstract: This application relates to new C-type natriuretic peptide (CNP) compounds, pharmaceutical compositions comprising these compounds, and these compounds for use as medicaments.
    Type: Grant
    Filed: November 1, 2023
    Date of Patent: September 3, 2024
    Assignee: Novo Nordisk A/S
    Inventors: Jakob Ewald, Anne Louise Bank Kodal, Jonas Alfred Karl Wilbs, Christian Poulsen, Peter Madsen, Kilian Waldemar Conde Frieboes, Christian Wenzel Tornoee
  • CO-AGONISTS OF THE GLP-1 AND AMYLIN RECEPTORS
    Publication number: 20240279299
    Abstract: The invention relates to a compound comprising a GLP-1 receptor agonist and an amylin receptor agonist. The invention also relates to a pharmaceutical formulation, suitable for but not limited to oral administration, which comprises such a compound. The compound and pharmaceutical formulation comprising it may be used for the medical treatment of subjects with overweight, obesity and associated co-morbidities.
    Type: Application
    Filed: February 29, 2024
    Publication date: August 22, 2024
    Inventors: Thomas Kruse, Anne Louise Bank Kodal, Johnny Madsen, Soeren Oestergaard, Wouter Frederik Johan Hogendorf, Christian Wenzel Tornoee, Lauge Schaeffer, Alice Ravn Madsen
  • CNP COMPOUNDS
    Publication number: 20240209028
    Abstract: This application relates to new C-type natriuretic peptide (CNP) compounds, pharmaceutical compositions comprising these compounds, and these compounds for use as medicaments.
    Type: Application
    Filed: November 1, 2023
    Publication date: June 27, 2024
    Inventors: Jakob Ewald Rasmussen, Anne Louise Bank Kodal, Jonas Alfred Karl Wilbs, Christian Poulsen, Peter Madsen, Kilian Waldemar Conde Frieboes, Christian Wenzel Tornoee
  • CO-AGONISTS OF THE GLP-1 AND AMYLIN RECEPTORS
    Publication number: 20230331803
    Abstract: The invention relates to a compound comprising a GLP-1 receptor agonist and an amylin receptor agonist. The invention also relates to a pharmaceutical formulation, suitable for but not limited to oral administration, which comprises such a compound. The compound and pharmaceutical formulation comprising it may be used for the medical treatment of subjects with overweight, obesity and associated co-morbidities.
    Type: Application
    Filed: December 19, 2022
    Publication date: October 19, 2023
    Inventors: Thomas Kruse, Anne Louise Bank Kodal, Johnny Madsen, Soeren Oestergaard, Wouter Frederik Johan Hogendorf, Christian Wenzel Tornoee, Lauge Schaeffer, Alice Ravn Madsen
  • Bifunctional compounds
    Patent number: 11130794
    Abstract: The application discloses compounds useful in treatment of diabetes, weight loss and/or reduction of cardiovascular risks. The compounds are bi-functional and therefore suitable as a simple treatment for patients that may benefit from treatment with both a GLP-1 receptor agonist and a PCSK9 inhibitor.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: September 28, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Christian Wenzel Tornoee, Anne Louise Bank Kodal, Steffen Reedtz-Runge, Lennart Lykke
  • Site selective conjugation of an oligonucleotide conjugate or a small molecule to a metal binding protein
    Patent number: 10925970
    Abstract: Provided are methods for site selective conjugation of an oligonucleotide conjugate to a metal binding protein comprising a metal binding site and for site selective conjugation of a small molecule conjugation compound (SMCoC) to an antibody comprising a metal binding site, metal binding protein conjugates obtainable by said methods, and uses of said metal binding protein conjugates.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: February 23, 2021
    Assignee: Affycon ApS
    Inventors: Kurt Vesterager Gothelf, Thomas Torring, Christian Bech Rosen, Anne Louise Bank Kodal, Michael Rosholm Mortensen
  • Bifunctional compounds
    Publication number: 20200231645
    Abstract: The application discloses compounds useful in treatment of diabetes, weight loss and/or reduction of cardiovascular risks. The compounds are bi-functional and therefore suitable as a simple treatment for patients that may benefit from treatment with both a GLP-1 receptor agonist and a PCSK9 inhibitor.
    Type: Application
    Filed: July 19, 2018
    Publication date: July 23, 2020
    Inventors: Christian Wenzel Tornoee, Anne Louise Bank Kodal, Steffen Reedtz-Runge, Lennart Lykke
  • SITE SELECTIVE CONJUGATION OF AN OLIGONUCLEOTIDE CONJUGATE OR A SMALL MOLECULE TO A METAL BINDING PROTEIN
    Publication number: 20170354743
    Abstract: Provided are methods for site selective conjugation of an oligonucleotide conjugate to a metal binding protein comprising a metal binding site and for site selective conjugation of a small molecule conjugation compound (SMCoC) to an antibody comprising a metal binding site, metal binding protein conjugates obtainable by said methods, and uses of said metal binding protein conjugates.
    Type: Application
    Filed: July 8, 2015
    Publication date: December 14, 2017
    Applicant: AFFYCON APS
    Inventors: Kurt Vesterager GOTHELF, Thomas T0RRING, Christian Bech ROSEN, Anne Louise Bank KODAL, Michael Rosholm MORTENSEN